Author

Chadwick Miller

Observed name: C.H. Miller

Institutions: Wake Forest University Health Sciences, Wake Forest University

Observed institutions: Atrium Health Wake Forest Baptist, Wake Forest University Health Sciences, University College London, Wake Forest University

OpenAlex ID: A5084220792

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

2023 · Samuel M Brown, Christina E Barkauskas, et al. · The Lancet Respiratory Medicine · 19

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4

Cardiac testing choices by physician specialty in the CMR-IMPACT trial

2025 · Michael W. Supples, Anna C. Snavely, et al. · The American Journal of Emergency Medicine · 1

U.s. Inhibitor Pilot Project: Study Design and Methods Validation

2007 · J.M. Soucie, C.H. Miller, et al. · Journal of Thrombosis and Haemostasis

Works count: 7

Citation count: 130

H-index: 4

I10-index: 4